Graphical abstract
Keywords
Categories
How to Cite
Abstract
Background: To explore the efficacy of powder of ginsengporia and atractylodis macrocephalae combined with aerobic exercise in the treatment of obese T2DM and its influence on glucose and lipid metabolism indices.
Results: Both groups of patients were given metformin drug treatment. The control group was given aerobic exercise intervention, and the observation group was given ginsengporia and atractylodis macrocephalae on the basis of the control group. The total effective rate of the observation group (95.74%) was higher than that of the control group (82.98%) (P < 0.05). After treatment, the main symptoms of the observation group were less (P < 0.05), such as thirst and lack of desire to drink, fatigue, loss of appetite, limb numbness and tingling, sticky stool, scanty dark urine, and lower total score. FPG, 2hPG, and HbA1c were lower (P < 0.05), FINS, HOMA-IR, and HOMA-β were higher (P < 0.05), TG, TC, and LDL-C were lower, and HDL-C levels were higher in the observation group (P < 0.05). After treatment, Nesfatin-1 and adiponectin were lower, visfatin and leptin were higher (P < 0.05), and GIP and GLP-1 levels were higher in the observation group (P < 0.05). No significant difference was found in the incidence of adverse reactions between the two groups (P > 0.05).
Conclusions: Powder of ginsengporia and atractylodis macrocephalae combined with aerobic exercise is effective in treating obese T2DM, which can alleviate clinical symptoms and the disorder of glucose and lipid metabolism, and improve the islet function and gastrointestinal function.
References
Dahl K, Brooks A, Almazedi F, et al. Oral semaglutide improves postprandial glucose and lipid metabolism, and delays gastric emptying, in subjects with type 2 diabetes. Diabetes Obes Metab, 2021;23(7):1594-1603. https://doi.org/10.1111/dom.14373 PMid: 33710717
Li S, Lin G, Chen J, et al. The effect of periodic ketogenic diet on newly diagnosed overweight or obese patients with type 2 diabetes.BMC Endocr Disord, 2022;22(1):34. https://doi.org/10.1186/s12902-022-00947-2 PMid: 35115003
Huang H, Jin J, Chen Y, et al. Visceral fat might impact left ventricular remodeling through changes in arterial stiffness in type 2 diabetes: A cross-sectional study. Int J Cardiol, 2022;368:78-84. https://doi.org/10.1016/j.ijcard.2022.08.033 PMid: 35988671
Yang Z, Mi J, Wang Y, et al. Effects of low-carbohydrate diet and ketogenic diet on glucose and lipid metabolism in type 2 diabetic mice. Nutrition, 2021;89:111230. https://doi.org/10.1016/j.nut.2021.111230 PMid: 33838492
Yuan X, Wang J, Yang S, et al. Effect of intermittent fasting diet on glucose and lipid metabolism and insulin resistance in patients with impaired glucose and lipid metabolism: A systematic review and meta-analysis. Int J Endocrinol, 2022;2022:6999907. https://doi.org/10.1155/2022/6999907 PMid: 35371260
Guidelines for clinical studies of new Chinese medicines: a trial [M]. China Pharmaceutical Science and Technology Press, 2002.
Pereira S, Cline DL, Glavas MM, et al. Tissue-specific effects of leptin on glucose and lipid metabolism. Endocr Rev, 2021;42(1):1-28. https://doi.org/10.1210/endrev/bnaa027 PMid: 33150398
Chaves A, Weyrauch LA, Zheng D, et al. Influence of maternal exercise on glucose and lipid metabolism in offspring stem cells: ENHANCED by Mom. J Clin Endocrinol Metab, 2022;107(8):e3353-e3365. https://doi.org/10.1210/clinem/dgac270 PMid: 35511592
Sánchez-García A, Simental-Mendía M, Simental-Mendía LE. Effect of proton-pump inhibitors on glucose and insulin metabolism on patients with type 2 diabetes: A systematic review and meta-analysis of randomized controlled trials. Curr Pharm Des, 2020;26(32):4007-4013. https://doi.org/10.2174/1381612826666200523170718 PMid: 32445448
Ghoreishi PS, Shams M, Nimrouzi M, et al. The effects of ginger (Zingiber officinale Roscoe) on non-alcoholic fatty liver disease in patients with type 2 diabetes mellitus: A randomized double-blinded placebo-controlled clinical trial. J Diet Suppl. 2023;21(3):294-312. https://doi.org/10.1080/19390211.2023.2263788 PMid: 37817641
Manda G, Rojo AI, Martínez-Klimova E, et al. Nordihydroguaiaretic acid: From herbal medicine to clinical development for cancer and chronic diseases. Front Pharmacol. 2020;11:151. https://doi.org/10.3389/fphar.2020.00151 PMid: 32184727
Mahdavi A, Moradi S, Askari G, et al. Effect of curcumin on glycemic control in patients with type 2 diabetes: A systematic review of randomized clinical trials. In: Guest PC, editor. Studies on biomarkers and new targets in aging research in Iran. Advances in experimental medicine and biology. Springer, Cham, 2021;1291:139-149. https://doi.org/10.1007/978-3-030-56153-6_8 PMid: 34331688
Liu Y, Xie X, Wang W, et al. A randomized controlled trial for the effect of Modified Shenling Baizhu Powder on delaying the illness progress of COPD stable phase patients (GOLD 1–2 stages): A study protocol. Medicine, 2020;99(43):e22700. https://doi.org/10.1097/MD.0000000000022700 PMid: 33120762
Jiao C, Zhang Q, Yang M, et al. Shenling Baizhu San ameliorates ulcerative colitis by regulating the gut microbiota and its tryptophan metabolites: A complementary medicine to mesalamine. J Ethnopharmacol, 2022;291(6):115145. https://doi.org/10.1016/j.jep.2022.115145 PMid: 35219821
Liu F, Liu Y, Liu M, et al. Efficacy of once-daily glucagon-like peptide-1 receptor agonist lixisenatide as an add-on treatment to basal insulin in Asian and white adults with type 2 diabetes mellitus: An individual-level pooled analysis of phase III studies. J Diabetes Investig, 2021;12(8):1386-1394. https://doi.org/10.1111/jdi.13504 PMid: 33475222
Zhang J, Schäfer SM, Kabisch S, et al. Implication of sugar, protein and incretins in excessive glucagon secretion in type 2 diabetes after mixed meals. Clin Nutr, 2023;42(4):467-476. https://doi.org/10.1016/j.clnu.2023.02.011 PMid: 36857956
Lai J, Jiang F, Zhuo X, et al. Effects of Shenling Baizhu powder on pyrotinib-induced diarrhea: Analysis of gut microbiota, metabonomics, and network pharmacology. Chin Med, 2022;17:140. https://doi.org/10.1186/s13020-022-00696-3 PMid: 36528679
Fiorentino TV, De Vito F, Suraci E, et al. Obesity and overweight are linked to increased sodium-glucose cotransporter 1 and glucose transporter 5 levels in duodenum. Obesity, 2023;31(3):724-731. https://doi.org/10.1002/oby.23653 PMid: 36746764
Karimi A, Azar PS, Reshadatjoo M, et al. A double-blind, randomized, clinical trial of the effects of Fumaria parviflora supplementation on metabolic parameters, anthropometric indices and serum levels of leptin, adiponectin and resistin in patients with type 2 diabetes. Journal of Biological Regulators and Homeostatic Agents, 2023;37(9):4825-4836. http://doi.org/10.23812/j.biol.regul.homeost.agents.20233709.470
Inada AC, Silva GT, Silva LPRD, et al. Therapeutic effects of Morinda citrifolia Linn. (Noni) aqueous fruit extract on the glucose and lipid metabolism in high-fat/high-fructose-fed Swiss mice. Nutrients, 2020;12(11):3439. https://doi.org/10.3390/nu12113439 PMid: 33182564
Huang B, Yang S, Ye S. Association between thyroid function and nonalcoholic fatty liver disease in euthyroid type 2 diabetes patients. J Diabetes Res, 2020;2020:6538208. https://doi.org/10.1155/2020/6538208 PMid: 32964054
He YL, Haynes W, Meyers CD, et al. The effects of licogliflozin, a dual SGLT1/2 inhibitor, on body weight in obese patients with or without diabetes. Diabetes Obes Metab, 2019;21(6):1311-1321. https://doi.org/10.1111/dom.13654 PMid: 30724002
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
Copyright (c) 2024 Electronic Journal of Biotechnology